said Professor Moon. "We only managed to harvest one stem cell line. We do not know whether this was due to something going wrong in the development of the cloned embryo, or whether we need to make small variations in our experimental procedures. But this will become clearer as we proceed.

"In the meantime, we believe that we have opened the door to an extraordinary revolution in medicine, where one day transplanting organs from other donors will become a thing of the past, and where millions of people with have access to life-saving therapies developed from their own DNA," he said.

'"/>

Contact: Mary Rice
mary.rice@blueprintpartners.be
European Society for Human Reproduction and Embryology
30-Jun-2004

Page: 1 2
Related biology news :

1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
2. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
3. Therapeutic cloning may be permitted at Newcastle University
4. PTC Therapeutics researchers identify biochemical pathway important for modulating cell growth
5. Critical Therapeutics announces issuance of US patent for novel anti-inflammatory technology
6. Medimmune and Critical Therapeutics to co-develop treatments for severe inflammatory diseases
7. Immerge BioTherapeutics announces new findings addressing key safety risk in xenotransplantation
8. Critical Therapeutics launches Phase I clinical trial of anti-inflammatory compound
9. Immerge BioTherapeutics announces identification of PERV receptor
10. Hemocellular Therapeutics establishes licensing agreement with UNC, ECU
11. Dana-Farber launches NFCR Center for Therapeutic Antibody Research and Engineering